Followers | 1319 |
Posts | 26918 |
Boards Moderated | 6 |
Alias Born | 12/10/2012 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 02, 2021 8:23:11 AM
Lets see what that was all about.
Interesting move there.
Something must be up
Heres the poster for Monalizumab........
https://pubmed.ncbi.nlm.nih.gov/31623687/
![](http://www.ncbi.nlm.nih.gov/pmc/articles/instance/6798508/bin/40425_2019_761_Fig1_HTML.jpg)
GO $IPHA
Recent IPHA News
- INNATE PHARMA ANNONCE SA PARTICIPATION A UNE PROCHAINE CONFERENCE INVESTISSEURS • Business Wire • 08/01/2024 05:00:00 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conference • Business Wire • 08/01/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024 • Business Wire • 07/25/2024 05:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juillet 2024 • Business Wire • 07/25/2024 05:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juin 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Innate Pharma partage de nouveaux résultats concernant l’essai de Phase 1/2 mené par Sanofi évaluant le NK cell engager SAR443579/IPH6101 dans divers cancers du sang • Business Wire • 06/17/2024 05:00:00 AM
- Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial • Business Wire • 06/17/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 10:03:42 AM
- Innate Pharma présente les résultats positifs de l’étude de Phase 2 TELLOMAK évaluant lacutamab dans le mycosis fongoïde • Business Wire • 06/04/2024 05:00:00 AM
- Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides • Business Wire • 06/04/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 10:03:49 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences • Business Wire • 05/28/2024 05:00:00 AM
- Innate Pharma annonce sa participation à de prochaines conférences investisseurs • Business Wire • 05/28/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/24/2024 10:35:36 AM
- Innate Pharma partage les abstracts sélectionnés pour le congres annuel de l’ASCO 2024 • Business Wire • 05/24/2024 05:00:00 AM
- Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting • Business Wire • 05/24/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 08:00:44 PM
- Outcome of Innate Pharma’s 2024 Annual General Meeting • Business Wire • 05/23/2024 08:00:00 PM
- Résultats de l’Assemblée Générale mixte du 23 mai 2024 • Business Wire • 05/23/2024 08:00:00 PM
- Innate Pharma: Clarification Regarding SAR443579 Designation • Business Wire • 05/21/2024 05:00:00 AM
- Innate Pharma: Clarification concernant le statut de SAR443579 • Business Wire • 05/21/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2024 10:01:12 AM
- Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress • Business Wire • 05/15/2024 05:00:00 AM
- Innate Pharma partage les abstracts sélectionnés pour le congrès 2024 de l’EHA • Business Wire • 05/15/2024 05:00:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM